🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Publication alert for India's first CAR-T cell therapy, NexCAR19 for B- cell leukemia and B-cell lymphoma. Much awaited publication.

Comparable outcomes to the 41BB CARs at a cost that’s more than 10 times cheaper 💐💐…. Albeena Nisar Rahul Purwar Gaurav Narula MD Hasmukh Jain

Ph-like ALL #hemepath

Super excited to share the results of our phase I decentralised manufacturing CAR T trial (VELCART) in B-ALL and DLBCL patients at CMC Vellore (Official). Excited for the phase II 😊 Hamenth Vikram Mathews Uday Kulkarni cell.com/molecular-ther…

Congratulations to the Vellore team! This is great work

Amazing, congratulations! POC CAR-T cell therapy at a fraction of the cost! Good luck with Phase II CMC Vellore (Official)

Excited to share a publication years in the making, our experience with CAR20.19 T cells in relapsed, refractory Mantle Cell Lymphoma now a. Excellent outcomes from IIT MCW Cancer Center Thanks to great collaborators Tim Fenske Mehdi Hamadani, MD and many more! ascopubs.org/doi/10.1200/JC…

Little wins ☺️ coming from the editor of one of the leading oncology journal. A big thanks to the editor for the kind gesture. 🙏

Safety, efficacy and total cost of point-of-care manufactured anti-CD19 CAR-T cell therapy in India: VELCART trial: Molecular Therapy Oncology cell.com/molecular-ther…

Ultra-Fast CAR-T. Exciting phase 1 results with improvements in both safety and efficacy 🌠Watch out for our poster at ISCT 2025. Promising study led by David Wald & Jan Joseph Melenhorst sciencedirect.com/science/articl…

Excited to host TCS-2025 (Annual workshops and conference of The Cytometry Society, India) in the City of JoY. SAVE THE DATES AND JOIN US IN THIS ACADEMIC EXTRAVAGANZA!!!! #FLOWTCS2025 THE CYTOMETRY SOCIETY Arun Kumar Arunachalam Prashant Tembhare Phaneendra Datari Kunal Sehgal sushantvinarkar

ICCS has revitalized their YouTube channel and will be releasing a range of #flowcytometry videos for all levels, from beginners to experts. The first video is on tandem dyes: youtube.com/watch?v=5cV7E9… Be sure to like and *subscribe* so that you don't miss new videos! #hemepath

A Perspective on Artificial Intelligence for Molecular Pathologists - The Journal of Molecular Diagnostics jmdjournal.org/article/S1525-…

Tweetorial Summary: Optimizing CAR T-Cell Therapy for Mantle Cell Lymphoma (MCL) 🧵 New paper by Arunachalam et al. in Journal of Clinical Oncology explores breakthroughs in CAR T-cell therapy for relapsed/refractory MCL. Dual-targeting CD19/CD20 CAR T (LV20.19) shows 100% response rate (88% CR)

Optimizing Chimeric Antigen Receptor T-Cell Therapy for Mantle Cell Lymphoma | Journal of Clinical Oncology ascopubs.org/doi/abs/10.120…

Thank you 😊

Thanks 𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM 😊

Today we’re introducing Copilot Mode in Edge, our first step in reinventing the browser for the AI age. My favorite feature is multi-tab RAG. You can use Copilot to analyze your open tabs, like I do here with papers our team has published in nature journals over the last year.